Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-10-02
2007-10-02
Brusca, John S (Department: 1631)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S024100, C703S011000
Reexamination Certificate
active
08249689
ABSTRACT:
A method for designing compounds specifically targeting RNA sequences, based on the discovery of short, specific sequences within RNA that are critical to function, using modeling of the compound to effect binding to the nucleotide sequences in the RNA in combination with secondary and/or tertiary structure associated with the minor groove of the RNA in the region of the critical sequences. In the preferred method, computer modeling is used along with analysis of the targeted RNA sequence to design molecules binding to the targeted RNA by covalent or hydrogen binding. Appropriate molecules are synthesized using known methodology that have the required structure and chemical characteristics to specifically bind the critical region of the RNA and thereby inhibit the function of the RNA. Molecules known to bind to RNA can also be modified using this method to increase specificity, and thereby decrease toxicity.
REFERENCES:
patent: 4464359 (1984-08-01), Suhadolnik et al.
patent: 4757055 (1988-07-01), Miller et al.
patent: 4898818 (1990-02-01), Nakai et al.
patent: 4924624 (1990-05-01), Suhadolnik et al.
Jeong, K.S. and Rebek, J. Jr. J. Amer. Chem. Soc. 110 3327-3328 (1998) “Molecular Recognition . . . Hydrogen Bonding and Aromatic . . . ”.
Rebek, J. Jr. et al., J Amer. Chem. Soc. 109 5033-5035 (1987) “Molecular Recognition: Hydrogen bonding and stacking interactions . . . ”.
Wilson, W.D. et al., Biochemistry 32 4098-4104 (1993) “The Search for Structure-Specific Nuleic Acid-Interative drugs . . . ”.
Yamada, T. et al., Nucleic Acids Research 8 5767-5777 (1980) “The Translocation Inhibitor Tuberactinomycin binds to nucleic . . . ”.
Wank, W. et al., J. Mol. Biol. 236 1001-1010 (1994) “Peptide Anibiotics of the Tuberactinomycin family as inhibitors . . . ”.
Askew, B., et al., J. Amer. Chem. Soc. 111 1082-190 (1989) “Molecular Recognition With Convengent Functional Groups . . . ”.
von der Haar, Von Friedrich et al.Angew Chem.93:250-256 (1981).
Brierley, Ian, et al.Cell57:537-547 (1989).
Mei, Houng-Yau, et al.Proc. Natl. Acad. Sci.86:9727-9731 (1989).
Yokoyama, Masayuki, et al.Chemical Abstracts109: 79550 No. 79541c (1988).
Itai, Akiki,Chemical Abstracts108:398 No. 62280y (1988).
Badger, John, et al.J. Mol. Biol.207:163-174 (1980).
McKinlay, et al.Ann. Rev. Pharmacol. Toxicol.29:111-122 (1989).
Perry, N.C., et al. inQSAR: Quantitative Structure Activity Relationships in Drug Design,Alan R. Liss, Inc. pp. 189-193 (1989).
Ripka, WilliamNew Scientist54-56 (Jun. 16, 1988).
Rouvinen, Juba, et al.Acta Pharmaceutica Fennica97:159-166 (1988).
Williams, et al.J. Am. Chem. Soc.111:1090-1094 (1989).
Benzing, T., et al.Science242:266-268 (1988).
Goodford, PeterChem. Abstracts111 No. 126283y (1989).
Weber, I., Proteins: Structure, Function, and Genetics 7:172-184 (1990).
Malim, M., et al.Cell60:675-683 (1990).
Schimmel, PaulCell58:9-12 (1989).
Endo, Yaeta, et al.The Journal of Biological Chemistry265:2216-2222 (1990).
Von der Haar, Friedrich et al.Chemical Abstracts94:346 No. 197448x (1981).
Park, Soon Jae, et al.The Journal of Biological Chemistry263:16527-16530.
Roberts, Stanley M., ed.Molecular Recognition: Chemical and Biochemical Problems,CRC Press, 1989.
Rebek, Jr., Julius,Science235:1478-1484 (1987).
Rebek, Jr., J., et al.J. Am. Chem. Soc.109:2426-2431 (1987).
Rebek, Jr., Julius, et al.J. Am. Chem. Soc.107:6736-6738 1985).
Askew, Ben, et al.J. Am. Chem. Soc.111:1082-1090 (1989).
Lewis, R. A. , et al.Proc. R. Soc. Lond.236:125-140 (1989).
Lewis, R.A., et al.Proc. R. Soc. Lond.236 :141-162 (1989).
Dreher, T.W., et al.J. Mol. Biol.201:41-55 (1988).
Jacks, Tyler, et al.Cell55:447-458 (1988).
Pleij, Cornelis, W.A., et al.Nucleic Acids Research13:1717-1731.
Haenni, Anne-Lise, et al.Progress in Nucleic Acid Research and Molecular Biology27:85-105.
Robertus, J.D., et al.Nature250:546-551 (1974).
Kim, S.H., et al.Science185:435-440 (1974).
Hou, Ya-Ming, et al.Nature333:140-145 (1988).
Park, Soon Jae, et al.Biochemistry28:2740-2746 (1989).
Francklyn, Christopher, et al.Nature337:478-481 (1989).
Hou, Ya-Ming, et al.Biochemistry28:6800-6804 (1989).
Schimmel, PaulBiochemistry28:2747-2759 (1989).
Hou, Ya-Ming, et al.Trends in Biochemical Sciences14:233-237 (1989).
Weber, I.T., et al.Science243:928-931 (1989).
Jones, T.Alwyn, et al.The EMBO Journal5:819-822 (1986).
Shi, Jian-Ping, et al.Science29:3621 (1990).
Brusca John S
Massachusetts Institute of Technology
Pabst Patent Group LLP
LandOfFree
Designing compounds specifically inhibiting ribonucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Designing compounds specifically inhibiting ribonucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Designing compounds specifically inhibiting ribonucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3824801